Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
11.96T | 11.47T | 11.81T | 8.75T | 5.77T | 6.64T | Gross Profit |
3.16T | 3.41T | 2.94T | 2.45T | 2.07T | 2.19T | EBIT |
480.13B | 534.25B | 506.52B | 387.65B | 366.33B | 424.26B | EBITDA |
972.93B | 840.83B | 995.32B | 751.49B | 626.87B | 674.31B | Net Income Common Stockholders |
196.64B | 224.62B | 280.98B | 210.77B | 179.26B | 218.19B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.30T | 1.56T | 1.67T | 1.42T | 2.20T | 1.36T | Total Assets |
5.96T | 10.59T | 10.55T | 8.74T | 6.95T | 6.00T | Total Debt |
1.02T | 3.84T | 4.04T | 2.96T | 1.79T | 1.02T | Net Debt |
-280.26B | 2.24T | 2.39T | 1.55T | -390.48B | -328.43B | Total Liabilities |
3.28T | 6.69T | 6.90T | 5.59T | 4.12T | 3.24T | Stockholders Equity |
2.54T | 3.72T | 3.47T | 2.98T | 2.67T | 2.60T |
Cash Flow | Free Cash Flow | ||||
446.25B | 215.37B | 430.59B | 312.05B | 210.16B | 237.33B | Operating Cash Flow |
987.44B | 673.01B | 841.48B | 736.48B | 560.00B | 576.67B | Investing Cash Flow |
-808.43B | -431.81B | -410.86B | -2.51T | -393.94B | -316.56B | Financing Cash Flow |
-219.33B | -377.06B | -270.37B | 937.08B | 690.54B | -213.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $747.33B | 38.76 | 22.23% | 0.92% | 5.07% | 25.86% | |
78 Outperform | $424.95B | 55.91 | 32.89% | 0.47% | 6.13% | 12.14% | |
77 Outperform | $15.56B | 42.22 | 30.81% | ― | 12.90% | 50.20% | |
73 Outperform | $47.79B | 19.68 | 26.59% | 1.73% | -1.94% | 23.94% | |
63 Neutral | $9.39B | 14.85 | 4.11% | 187.30% | 3.96% | 6.50% | |
62 Neutral | $37.14B | 32.75 | 4.37% | 1.19% | -4.16% | 33.19% | |
60 Neutral | $42.42B | 10.51 | 29.12% | 4.79% | -0.79% | -0.90% |